JeffreyACohenMD

PubMed

• Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.
  Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer Graves, Scott S Zamvil, Scott D Newsome, Amy Kunchok> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2024 May 1
• Multiple sclerosis can be diagnosed solely with dissemination in space: Commentary.
  Marisa P McGinley, Jeffrey A Cohen> ;Multiple Sclerosis. 2024 Apr 14
• Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability.
  Alise K Carlson, Moein Amin, Jeffrey A Cohen> ;Drugs. 2024 Mar 1
• Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis.
  Li, Y., Thompson, N., Milinovich, A., Galioto, R., Morgan, A., Abbatemarco, J., Cohen, J., Ontaneda, D., Punia, V., Rae-Grant, A., Kunchok, A.> ;Neurology. 2024 Feb 27
• Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis.
  Lindsay A Ross, Lisa M Stropp, Jeffrey A Cohen> ;Neurologic Clinics. 2024 Feb 1
• Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis.
  Nakamura, K., Thoomukuntla, B., Bena, J., Cohen, J., Fox, R., Ontaneda, D.> ;Multiple Sclerosis. 2024 Mar 1
• Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
  Sanem P Uysal, Yadi Li, Nicolas R Thompson, Alex Milinovich, Justin R Abbatemarco, Jeffrey A Cohen, Devon S Conway, Daniel Ontaneda, John A Morren, Amy Kunchok> ;Annals of Clinical and Translational Neurology. 2024 Mar 1
• Priority setting: women's health topics in multiple sclerosis.
  Finlayson, M., Amato, M., Hellwig, K., Tintore, M., Vukusic, S., Salter, A., Marrie, R., Ross, L., Cohen, J.> ;Frontiers in Neurology. 2024 Jan 1
• Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis.
  Albert Aboseif, Yadi Li, Moein Amin, Brittany Lapin, Alex Milinovich, Justin R Abbatemarco, Jeffrey A Cohen, Vineet Punia, Alex D Rae-Grant, Rachel Galioto, Amy Kunchok> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2024 Jan 1
• Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial.
  Comi, G., Selmaj, K., Hartung, H., Sheffield, J., Krakovich, A., Tatosian, D., Cheng, C., Reardon, J., Khaychuk, V., Riolo, J., Silva, D., Naismith, R., Cohen, J., Bar...> ;Multiple Sclerosis. 2024 Feb 1
• 1 citations
  Magnetic resonance fingerprinting in multiple sclerosis.
  Daniel Ontaneda, Vikas Gulani, Anagha Deshmane, Amisha Shah, Deepti K Guruprakash, Yun Jiang, Dan Ma, Elizabeth Fisher, Richard A Rudick, Praneeta Raza, Meghan Kilbane...> ;Multiple Sclerosis and Related Disorders. 2023 Nov 1
• Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.
  Stephen L Hauser, Ronald Zielman, Ayan Das Gupta, Jing Xi, Dee Stoneman, Goeril Karlsson, Derrick Robertson, Jeffrey A Cohen, Ludwig Kappos> ;Multiple Sclerosis. 2023 Oct 1
• 1 citations
  Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis.
  Kunio Nakamura, Yufan Zheng, Kedar R Mahajan, Jeffrey A Cohen, Robert J Fox, Daniel Ontaneda> ;Multiple Sclerosis. 2023 Sep 1
• 4 citations
  Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
  Andrew J Solomon, Georgina Arrambide, Wallace J Brownlee, Eoin P Flanagan, Maria Pia Amato, Lilyana Amezcua, Brenda L Banwell, Frederik Barkhof, John R Corboy, Jorge C...> ;The Lancet. Neurology. 2023 Aug 1
• Commentary: Solomon AJ et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol 2023; 22(8): 750-768.
  Jeffrey A Cohen> ;Multiple Sclerosis. 2023 Aug 1
• 1 citations
  The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis.
  Ebtesam Alshehri, Jeffrey A Cohen, Daniel Ontaneda, Kunio Nakamura, Scott Husak, Thomas E Love, Robert J Fox, Farren Bs Briggs, Devon S Conway> ;Multiple Sclerosis. 2023 Jun 1
• Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?
  Jeffrey A Cohen, Anne H Cross> ;JAMA Neurology. 2023 Jul 1
• 3 citations
  Incorporating the Central Vein Sign Into the Diagnostic Criteria for Multiple Sclerosis.
  Daniel Ontaneda, Jeffrey A Cohen, Pascal Sati> ;JAMA Neurology. 2023 Jul 1
• 5 citations
  Reproductive issues and multiple sclerosis: 20 questions.
  Alise K Carlson, Daniel Ontaneda, Mary R Rensel, Jeffrey A Cohen, Amy Kunchok> ;Cleveland Clinic Journal of Medicine. 2023 Apr 3
• 2 citations
  Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week d...
  Lana Zhovtis Ryerson, John F Foley, Gilles Defer, Jeffrey A Cohen, Douglas L Arnold, Helmut Butzkueven, Gary Cutter, Gavin Giovannoni, Joep Killestein, Heinz Wiendl, S...> ;Multiple Sclerosis and Related Disorders. 2023 Apr 1
• 85 citations
  Multiple sclerosis progression: time for a new mechanism-driven framework.
  Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee, Jeffrey A Cohen, Jorge Correale, Jennifer Graves, Ruth Ann Marrie, Xavier Montalban, V Wee Yong, Alan J Thompson, Dan...> ;The Lancet. Neurology. 2023 Jan 1
• MRI Features of Anti-Ma1/Ma2 Paraneoplastic Neurologic Syndrome.
  Amy C Kunchok, Daniel Ontaneda, Jonathan Lee, Alexander Rae-Grant, Nancy Foldvary-Schaefer, Jeffrey A Cohen, Stephen E Jones> ;Neurology. 2022 Nov 15
• 12 citations
  Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial.
  Bruce Ac Cree, Krzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi, Amit Bar-Or, Douglas L Arnold, Hans-Peter Hartung, Xavier Montalbán, Eva K Havrdová, James K Shef...> ;Multiple Sclerosis. 2022 Oct 1
• 1 citations
  Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.
  Kunio Nakamura, Marisa P McGinley, Stephen E Jones, Mark J Lowe, Jeffrey A Cohen, Paul M Ruggieri, Daniel Ontaneda> ;Journal of Neuroimaging. 2023 Jan 1
• 6 citations
  Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
  Jeffrey A Cohen, Fred D Lublin, Christoper Lock, Daniel Pelletier, Tanuja Chitnis, Munish Mehra, Yael Gothelf, Revital Aricha, Stacy Lindborg, Chaim Lebovits, Yossef L...> ;Multiple Sclerosis. 2023 Jan 1
• Join now to see all